SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Fujisawa Pharmaceutical Co., Ltd

Headquarters : 4-7, Doshomachi 3-chome, Chuo-ku, Osaka 541-8514 Japan Japan web www.fujisawa.co.jp tel. 6-6202-1141 analytics

Brands

name
click to compare prices
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Fujisawa Pharmaceutical Co., Ltd , group and subsidiaries

Fraud 1 Offshore 3 Sales 3 Bn $.€ /year Influence 1
[click on the rating for the method or on the number for the data]

country
address & contact : production type
incentive source
South Korea South Korea
Fujisawa Korea Ltd. 10F. Haesung No.1 Bldg., 942, Kangnam-ku, Seoul & 2-564-3180 :
 
Hong-Kong Hong-Kong
Fujisawa Hong Kong Ltd. Grand Century Place, 193 Prince Edward Road West, Mongkok, Kowloon & 852-2377-9801 :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Ireland Ireland
Killorgin : R&D
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Les Echos
Ireland Ireland
Fujisawa Ireland Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
Klinge Pharma AG, Bachstrasse 10, CH-8280 Kreuzlingen & 71-6724882 :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2000Aoki, Hatsuo
See the photo of: Aoki, Hatsuo Chief Executive Officer;
2000Fujisawa, Tomokichiro
See the photo of: Fujisawa, Tomokichiro Director;
2000Fujiyama, Akira
See the photo of: Fujiyama, Akira Chairman of the Board;
2000Iida, Michio
See the photo of: Iida, Michio Vice-president;
2000Kobayashi, Kanji
See the photo of: Kobayashi, Kanji Director;
2000Kojima, Akiro
See the photo of: Kojima, Akiro Director;
» More executive salaries for Fujisawa Pharmaceutical Co., Ltd
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2003
8000
2002
7700
» More restructuring at Fujisawa Pharmaceutical Co., Ltd
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 2 informations, access to subscribers
» More restructuring at Fujisawa Pharmaceutical Co., Ltd
» Layoff plans and labour conditions in 2007

  • Subsidy

  • Advertising & marketing

yearfinancial misdemeanorsalesincome source
2003   3,190,24   billion US$
2002   2,570,2   billion US$
2002 Fined for fixing the price and sharing the european market for sodium gluconate: 3,6 million euros.     Commission Européenne
2001   2,360,16   billion US$
2000   2,740,22   billion US$
» More financial data for Fujisawa Pharmaceutical Co., Ltd
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 5 informations, access to subscribers
» More financial data for Fujisawa Pharmaceutical Co., Ltd
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
» More influence from Fujisawa Pharmaceutical Co., Ltd
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 1 informations, access to subscribers
» More influence from Fujisawa Pharmaceutical Co., Ltd
» Influence in 2007


Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS